Fulgent Genetics (FLGT) vs Waters (WAT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Waters (WAT) has outperformed Fulgent Genetics (FLGT) over the past year, gaining 31.0% versus a loss of 8.8%. Over five years, WAT leads with a +24.5% price change compared with -73.3% for FLGT. Waters is the larger company by market cap ($42.13 billion vs $572.9 million), about 73.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FLGT | WAT |
|---|---|---|
| Share price | $20.82 | $429.13 |
| Market cap | $572.87M | $42.13B |
| 1-day change | +1.22% | -1.57% |
| YTD return | -20.75% | +12.98% |
| 1-year return | -8.80% | +30.97% |
| 5-year return | -73.31% | +24.49% |
| P/E ratio (TTM) | — | 108.64 |
| Forward P/E | — | 25.95 |
| EPS (TTM) | $-2.82 | $3.95 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $3.17B |
| Revenue growth (YoY) | — | +6.99% |
| Net income (latest FY) | — | $642.63M |
| Gross margin | — | 59.28% |
| Operating margin | — | 25.36% |
| Net margin | — | 20.30% |
| 52-week high | $31.04 | $454.54 |
| 52-week low | $13.46 | $282.77 |
| Distance from 52-week high | -32.93% | -5.59% |
| Analyst consensus | none | buy |
| Avg. price target upside | -8.74% | +6.42% |
| Average volume | 301.04K | 777.61K |
| Shares outstanding | 27.52M | 98.19M |
| Employees | 1,315 | 16,000 |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics & Research | Diagnostics & Research |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Waters is about 73.6 times larger than Fulgent Genetics by market value ($42.13B vs $572.87M).
- WAT has outperformed FLGT by 39.8 percentage points over the past year.
About Fulgent Genetics
FLGT stock →Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
Healthcare · Diagnostics & Research · 1,315 employees
About Waters
WAT stock →Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA.
Healthcare · Diagnostics & Research · 16,000 employees
FLGT vs WAT FAQ
Which is bigger, Fulgent Genetics or Waters?
Waters (WAT) is larger, with a market capitalization of $42.13B compared with $572.87M for Fulgent Genetics (FLGT).
Which stock has performed better over the past year, FLGT or WAT?
WAT returned +30.97% over the past 12 months, compared with -8.80% for FLGT (price return, excluding dividends). Past performance does not predict future results.
Are Fulgent Genetics and Waters in the same industry?
Yes. Both are classified in the Diagnostics & Research industry within the Healthcare sector.